A new study conducted by Baxter International Inc. indicates healthcare systems in the United Kingdom, Germany, Italy and Spain see value in supporting remote monitoring technology for chronic health conditions, including end-stage renal disease (ESRD), according to a press release from Baxter.
The study indicates remote monitoring may improve access to care, decrease hospitalizations and reduce treatment costs by helping healthcare professionals manage patients’ treatments and improve adherence.
The study, ”Remote Monitoring of Chronic Diseases: A Landscape Assessment of Policies in Four European Countries” observed a growing number of funding approaches and policies supporting remote monitoring for chronic diseases, such as chronic heart failure, chronic obstructive pulmonary disease and diabetes, the press release notes. The study also reports a survey of healthcare payers and policy makers in these countries indicating the value of remote monitoring is perceived to be moderate to high in these chronic diseases, as well as ESRD.
Results demonstrated the value of remote monitoring was perceived to be moderate to high across all the chronic disease states. The most common factors contributing to highest ratings for remote monitoring included situations where patients:
- live in rural areas or without easy access to a doctor or hospital
- have just been discharged from the hospital and require close monitoring or follow-up
- are suffering from rare, more serious or multiple diseases.
The study also explored overall policies and reimbursement for remote monitoring in these countries. Results found several policies and initiatives existed to promote adoption of remote monitoring, and most of the studied countries had initiated regional or national pilot projects to further evaluate remote monitoring. Overall, the study notes a lack of national tariffs.
However, regional reimbursement programs for remote monitoring exist in some countries. Although public support for remote monitoring is present in the countries studied, implementation is generally inconsistent. It was also recognized that barriers to wider adoption exist including the need to align incentives and address any potential impact on physician budgets.